New Cooperative Catalysis Concepts for Asymmetric Synthesis
New Cooperative Catalysis Concepts for Asymmetric Synthesis
批准号:
10387927
负责人:
Karl A Scheidt
金额:
$8.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-05-31
关键词:
AcidsAddressBiologicalBiological ProcessBiologyCatalysisChemicalsChemistryClinicalDevelopmentFamilyGoalsHealthHumanInvestigationKnowledgeMedicalMedicineMethodologyMethodsNatural ProductsProcessReactionResearchResearch ActivitySocietiesTherapeuticcarbenedisorder preventioninnovationmethod developmentnovelnovel therapeuticsprograms
中文摘要
项目摘要
21世纪世纪医学的进步对社会产生了巨大的影响,但仍然迫切需要新的
利用已知的生物学过程或具有新的作用机制的治疗剂。的
开发新的,选择性的,使化学方法,以推动快速调查的
天然产物和相关探针的反应性和生物活性对于了解其
本发明的目的是提供用于治疗和/或预防疾病的新的治疗剂。一
我们的研究计划的主要目标是发现和开发新的合作催化,立体选择性
转换,促进高效率的建设有价值的材料。新方法
本提案中提出的建议a)具有重大和非常令人鼓舞的初步结果,以及B)受到启发
通过生物活性分子/天然产物,随后将促进这些
目标和潜在的应用对临床终点。创新的合作催化战略,
正在追求与发现新潜力有关的生物过程的意志力研究
产生靶向生物活性分子,同时提供广泛的解决方案,
合成相关的化合物家族。
本研究的具体目标是:a)探索新的,合作的卡宾催化过程,B)
立体选择性催化碳阳离子驱动的转化的发展,c)刘易斯的研究
酸催化的N-Umpolung型自由基反应,和d)光催化产生的反应性的合并
生物催化。我们预计,这些研究活动将从根本上促进人类健康,
提供创新的策略和策略,以获得许多重要类别的健康相关化合物。
英文摘要
Project Summary
Advances in 21st century medicine have greatly impacted society, but a serious need persists for new
therapeutics that either exploit known biological processes or possess novel mechanisms of action. The
development of new, selective, and enabling chemical methodology to drive the rapid investigation of the
reactivity and biological activity of natural products and related probes is vital to understanding their
mechanism of action and developing new therapeutics for the treatment and/or prevention of disease. A
primary goal of our research program is to discover and develop new cooperative catalytic, stereoselective
transformations that facilitate the highly efficient construction of valuable materials. The new methods
advanced in this proposal have a) significant and highly encouraging preliminary results, and b) been inspired
by bioactive molecules/natural products that will subsequently facilitate the efficient construction of these
targets and potential applications towards clinical endpoints. The innovative cooperative catalytic strategies we
are pursuing will power investigations of biological processes relevant to the discovery of new potential
therapies and strategies that generate the targeted bioactive molecules while providing broad solutions to
synthesizing related families of compounds.
The specific goals of this research are: a) the exploration of new, cooperative carbene catalyzed processes, b)
the development of stereoselective catalytic carbocation-driven transformations, c) the investigation of Lewis
acid-catalyzed -Umpolung type radical reactions, and d) the merger of photocatalytically-generated reactivity
with biocatalysis. We anticipate that these research activities will fundamentally advance human health by
providing innovative tactics and strategies to access many important classes of health relevant compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Cooperative Catalysis Concepts for Asymmetric Synthesis
-
批准号:10165756
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2020
-
负责人:Karl A Scheidt
-
依托单位:
New Cooperative Catalysis Concepts for Asymmetric Synthesis
-
批准号:10416024
-
项目类别:
-
资助金额:$39.34万
-
财政年份:2020
-
负责人:Karl A Scheidt
-
依托单位:
New Cooperative Catalysis Concepts for Asymmetric Synthesis
-
批准号:10642748
-
项目类别:
-
资助金额:$39.34万
-
财政年份:2020
-
负责人:Karl A Scheidt
-
依托单位:
Discovery of Selective MAP2K4 Inhibitors to Target Metastasis
-
批准号:8888686
-
项目类别:
-
资助金额:$34.68万
-
财政年份:2015
-
负责人:Karl A Scheidt
-
依托单位:
An Integrated Open-Access HT Preparative Chromatography System for Molecular Medi
-
批准号:7596144
-
项目类别:
-
资助金额:$41.05万
-
财政年份:2009
-
负责人:Karl A Scheidt
-
依托单位:
Synthesis of Anticancer Pyran Natural Products
-
批准号:7894732
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2009
-
负责人:Karl A Scheidt
-
依托单位:
Synthesis of Anticancer Pyran Natural Products
-
批准号:7655031
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2009
-
负责人:Karl A Scheidt
-
依托单位:
Carbene Catalysis Strategies for Organic Synthesis
-
批准号:8412083
-
项目类别:
-
资助金额:$5.41万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
Carbene Catalysis Strategies for Organic Synthesis
-
批准号:8727579
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
New Polarity Reversal Strategies for Organic Synthesis
-
批准号:7681475
-
项目类别:
-
资助金额:$29.29万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
New Polarity Reversal Strategies for Organic Synthesis
-
批准号:7765151
-
项目类别:
-
资助金额:$3.7万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
Carbene Catalysis Strategies for Organic Synthesis
-
批准号:9134771
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
Carbene Catalysis Strategies for Organic Synthesis
-
批准号:8325503
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
New Polarity Reversal Strategies for Organic Synthesis
-
批准号:7488762
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
Carbene Catalysis Strategies for Organic Synthesis
-
批准号:8187637
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
New Polarity Reversal Strategies for Organic Synthesis
-
批准号:7922493
-
项目类别:
-
资助金额:$25.31万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
Carbene Catalysis Strategies for Organic Synthesis
-
批准号:8545179
-
项目类别:
-
资助金额:$27.19万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
New Polarity Reversal Strategies for Organic Synthesis
-
批准号:7287819
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
New Polarity Reversal Strategies for Organic Synthesis
-
批准号:7092752
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2006
-
负责人:Karl A Scheidt
-
依托单位:
CATALYTIC ENANTIOSELECIVE SYNTHESIS OF ALLYLAMINES
-
批准号:6179245
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2000
-
负责人:Karl A Scheidt
-
依托单位:
海外基金